White Paper: Nasal Decolonization's Broadening Application: Replacing Contact Precautions


An increase in prevalence in healthcare settings across the continuum of care over several decades has resulted in MRSA and other multidrug-resistant organisms (MDROs) being given priority as targets of reduction efforts by several regulatory and advisory bodies. These include the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA) and the Centers for Disease Control and Prevention (CDC).

Despite the continued growth of evidence that universal decolonization is more effective than targeted screen and isolate protocols in reducing HAIs, concerns for antibiotic over-use has fostered the reluctance of some to adopt the universal approach. With the availability of a nonantibiotic nasal decolonization alternative, infection preventionists, infectious disease personnel, nursing managers accountable for HAIs on their units, surgeons and other professionals responsible for patient care and safety have reason to re-consider the advantages of universal decolonization. These advantages extend to several areas in which the reduction of MRSA infection and transmission is paramount, most certainly including efforts to reduce the use of CP.

This Whitepaper will discuss:

  • The history of contact precautions for patients with MRSA
  • Assessing the benefits of contact precautions
  • Negative impacts associated with the use of contact precautions
  • The road to reducing the use of contact precautions

Sponsored by


Nozin® Nasal Sanitizer® antiseptic is clinically proven to reduce Staph aureus nasal carriage without iodine or antibiotics. The leader in nasal decolonization, Nozin is at the forefront of providing innovative infection control solutions in hospitals and healthcare facilities. Nozin patented technology for use by patients and healthcare professionals can help reduce pathogen burden in high-risk areas and lower infection control costs. Based in Maryland, Global Life Technologies Corp. manufactures Nozin product. www.nozin.com


Recent Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Antimicrobial Resistance (Adobe Stock unknown)
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today's topic of the month: Mental Health
Infection Control Today Topic of the Month: Mental Health
Lucy S. Witt, MD, investigates hospital bed's role in C difficile transmission, emphasizing room interactions and infection prevention
Mindful MD: 6 Ways Mindfulness Restores Your Autonomy and Cures Healthcare Burnout  (Photo credit: Tori Whitacre Martonicz)
Related Content